CD83 Expression Is a Sensitive Marker of Activation Required for B Cell and CD4+ T Cell Longevity In Vivo
Charlene M. Prazma(Duke Medical Center), Thomas F. Tedder(Duke Medical Center), Manabu Fujimoto(Osaka Gakuin University), Yoko Fujimoto(Duke Medical Center), Norihito Yazawa(The University of Tokyo)
Cited by 95
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
|The Journal of Experimental Medicine|2004|631
Sequential contribution of L- and P-selectin to leukocyte rolling in vivo.
|The Journal of Experimental Medicine|1995|585